Announcements Trials
Browse Landscape

Phase

Phase 1 362Phase 1/2 203Phase 2 71Phase NA 69Phase EARLY_PHASE1 40Phase 3 15Phase 4 3Phase 2/3 3

Status

Completed 6Recruiting 3Unknown 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 75Other hematologic neoplasm 32Lymphoid 27Genitourinary 27Gynecologic 25Thoracic 23Head & Neck 20Breast 17Plasma cell 9Dermatologic 9CNS 8Tumor-Agnostic 5Myeloid 5Endocrine 5Other 4Sarcoma 3Other solid neoplasm 3NET 3Classical hematology 3

Conditions

Retinoblastoma 1Resectable MMR-deficient Solid Tumors 1Advanced Intrahepatic Cholangiocarcinoma 1

Interventions

balstilimab 1Vincristine 1Topotecan 1Platinum Compounds 1Melphalan 1Hyperthermia, Induced 1Etoposide 1Drug Therapy 1Cryotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Recruiting × Other solid neoplasm × Clear all
NCT06279130 2026-03-05

NEOASIS

The Netherlands Cancer Institute

Phase 2/3 Recruiting
133 enrolled
Other solid neoplasm

Resectable MMR-deficient Solid Tumors

NCT04353375 2025-12-31

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

Hutchmed

Phase 2/3 Recruiting
235 enrolled
GastrointestinalOther solid neoplasm

Advanced Intrahepatic Cholangiocarcinoma

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting
225 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡